
Rajeev Mukundan
About Rajeev Mukundan
Data last updated:
Rajeev Mukundan was a Director at Famy Life Sciences Private Limited (2023–2025), Director at Tianish Laboratories Private Limited (2023–2024) and Director at Senador Laboratories Private Limited (2023–2024), and held 2 more directorships. The companies operate in Trading and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Feb 2023 | 2008 | ₹2.36 Cr (FY 2025) | Active | |
| Director | 25 Mar 2023 | 2023 | ₹2,060 Cr (FY 2024) | Amalgamated | |
| Director | 31 Mar 2023 | 2023 | ₹29.13 Cr (FY 2024) | Active | |
| Additional Director | 05 Dec 2013 | 2004 | Amalgamated | ||
| Additional Director | 05 Dec 2013 | 2007 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Mukundan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Mukundan
Rajeev Mukundan was first appointed on 05 Dec 2013 as Additional Director at Agila Specialties Private Limited. The most recent appointment on record is 31 Mar 2023 at Senador Laboratories Private Limited.
Rajeev Mukundan held 5 earlier board appointments: Famy Life Sciences Private Limited (Director, 10 Feb 2023 to 28 Mar 2025); Tianish Laboratories Private Limited (Director, 25 Mar 2023 to 01 Mar 2024); Senador Laboratories Private Limited (Director, 31 Mar 2023 to 16 Feb 2024); Agila Specialties Private Limited (Additional Director, from 05 Dec 2013); Onco Therapies Limited (Additional Director, from 05 Dec 2013).